Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Verona’s ensifentrine improves lung function in Phase II trial

DPI formulation of ensifentrine shows improvement in patients with moderate-to-severe COPD. Credit: kalhh via Pixabay.



  • Verona’s ensifentrine improves lung function in Phase II trial

Go Top